Published on
March 10, 2026
- 16:00 GMT
Acorn Biolabs Advances Autologous Regenerative Platform with Injectable Clinical Study for Facial Rejuvenation
Initial treatments are underway in randomized study of Acorn’s personalized autologous injectable for improving facial skin quality. TORONTO, ON, CANADA, March 10, 2026 /EINPresswire.com/ -- Acorn Biolabs, a regenerative medicine company developing …
Distribution channels:
Beauty & Hair Care, Healthcare & Pharmaceuticals Industry
...
